CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Delisting notice
- EFFECT Other Notice of Effectiveness
- 8-K Event Material agreement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS Other Draft Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Open-market sale Chief R&D Officer sold 10,300 shares at $1.01 ($10,403)
- 4 Open-market sale Chief Legal Officer sold 11,040 shares at $1.01 ($11,150)
- 4 Open-market sale President & CEO sold 23,774 shares at $1.01 ($24,012)
Page 8 of 100 · 1,982 filings